These outcomes, together with a prior report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two support the thought of focusing on ACKR3 as a singular approach to modulate the opioid program, which could open up new therapeutic avenues for opioid-linked Conditions.Scientists think that blocking this